Papers
Topics
Authors
Recent
Search
2000 character limit reached

Actively evaluating and learning the distinctions that matter: Vaccine safety signal detection from emergency triage notes

Published 24 Jul 2025 in cs.AI and cs.CL | (2507.18123v1)

Abstract: The rapid development of COVID-19 vaccines has showcased the global communitys ability to combat infectious diseases. However, the need for post-licensure surveillance systems has grown due to the limited window for safety data collection in clinical trials and early widespread implementation. This study aims to employ Natural Language Processing techniques and Active Learning to rapidly develop a classifier that detects potential vaccine safety issues from emergency department notes. ED triage notes, containing expert, succinct vital patient information at the point of entry to health systems, can significantly contribute to timely vaccine safety signal surveillance. While keyword-based classification can be effective, it may yield false positives and demand extensive keyword modifications. This is exacerbated by the infrequency of vaccination-related ED presentations and their similarity to other reasons for ED visits. NLP offers a more accurate and efficient alternative, albeit requiring annotated data, which is often scarce in the medical field. Active learning optimizes the annotation process and the quality of annotated data, which can result in faster model implementation and improved model performance. This work combines active learning, data augmentation, and active learning and evaluation techniques to create a classifier that is used to enhance vaccine safety surveillance from ED triage notes.

Summary

No one has generated a summary of this paper yet.

Paper to Video (Beta)

No one has generated a video about this paper yet.

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.

Tweets

Sign up for free to view the 1 tweet with 0 likes about this paper.